Full-Time

Aesthetic Injector

NP/PA

Annie Aesthetic

Annie Aesthetic

11-50 employees

Consolidates med spa clinics through acquisitions

No salary listed

Roswell, GA, USA

In Person

Category
Medical, Clinical & Veterinary (1)
Required Skills
Inventory Management
Patient Care
HIPAA

Get referred to Annie Aesthetic

See people who can refer or advise you

Requirements
  • Licensure in Georgia is required.
  • A minimum of 3 years of experience administering cosmetic injectables, including neuromodulators, hyaluronic acid fillers, and biostimulators, is required.
  • The candidate must be willing to work in a fast-paced, goal-oriented environment.
  • Strong customer service orientation is required.
Responsibilities
  • Conduct in-depth patient consultations, including taking medical histories, explaining procedure risks and benefits, and obtaining signed consents.
  • Administer cosmetic injections, including neurotoxins, dermal fillers, and other aesthetic modalities, while ensuring patient satisfaction.
  • Maintain accurate documentation of patient needs, preferences, and services provided in medical files.
  • Complete continuing education and training when needed or requested, and stay current with industry developments.
  • Learn new techniques, procedures, and brand language.
  • Maintain professionalism when interacting with clients, pharmaceutical representatives, and staff members.
  • Collaborate with healthcare professionals and administrative counterparts to provide comprehensive patient care.
  • Comply with state laws and regulations regarding sanitation, protocols, and safety.
  • Maintain patient confidentiality in accordance with Health Insurance Portability and Accountability Act guidelines and company policy.
  • Inspect treatment rooms for cleanliness and organization and manage inventory.

Annie Aesthetic consolidates U.S. medical aesthetics clinics through a buy-and-build strategy, partnering with or acquiring best-in-class med spa brands. The company provides growth capital, marketing, technology, operations, talent, HR, and regulatory support to its partner clinics. It offers flexible partnership structures, including full buyouts, partial cash-outs with rolled ownership, and growth-focused non-cash-out arrangements. With private equity backing and an operations-focused platform, its goal is to build a nationwide network of high-performing med spa brands and improve profitability across the network.

Company Size

11-50

Company Stage

N/A

Total Funding

N/A

Headquarters

New York

Founded

N/A

Get referred to Annie Aesthetic

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • September 2025 Series B from InterAlpen and Brookside funded more acquisitions and leadership hiring.
  • Revenue reached a $65 million run-rate by September 2025, then grew 14% year-over-year.
  • August 2026 job postings for clinical operations signal active expansion across Western U.S. clinics.

What critics are saying

  • Zenoti integrations, provider turnover, and 100-day post-acquisition execution failures destroy add-on economics.
  • Private equity roll-up multiples compress if Botox competitors like Ideal Image outspend Annie on marketing.
  • A bad compliance event at one clinic can trigger payer scrutiny, lawsuits, and existential brand damage.

What makes Annie Aesthetic unique

  • Sam Schloss and Mark launched Annie Aesthetic in 2022 with permanent capital backing.
  • Annie Aesthetic centralizes marketing, HR, legal, technology, and compliance for partner clinics.
  • By August 2026, Annie runs 12 brands across 18 locations with 2026 hiring support.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Employee Discounts

Growth & Insights and Company News

Headcount

6 month growth

3%

1 year growth

3%

2 year growth

7%
Clarke Broadcasting
Sep 15th, 2025
Tucker’s Farm Corporation Raises Series B for Medspa Platform, Reaching $65 Million in Revenue, and Expands Credit Facility

Tucker’s Farm Corporation Raises Series B for Medspa Platform, Reaching $65 Million in Revenue, and Expands Credit Facility